Evoke Wealth’s MaxLinear MXL Stock Holding History

Evoke Wealth’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16	Closed	-$1K	–	851
2022 Q3	$1K	Hold	16	–	–	﹤0.01%	1128
2022 Q2	$1K	Buy	+16	New	+$671	﹤0.01%	1122

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Evoke Wealth's MXL Position: Q4 2022 in Review

Evoke Wealth sold out of MaxLinear (MXL) in Q4 2022, closing a stake of 16 shares — an estimated $1K sold.

Evoke Wealth first reported a position in MXL in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 282 funds tracked by Wall St. Rank hold MXL as of Q4 2022.

Evoke Wealth reported no remaining MaxLinear position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 16 MaxLinear shares in Q4 2022, an estimated $1K.
Evoke Wealth first reported a position in MaxLinear in Q2 2022 and held it in 2 quarters.
Evoke Wealth's MaxLinear position peaked at $1K in Q3 2022.
282 funds tracked by Wall St. Rank held MaxLinear as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.